SB 219 New Mexico Senate · 2025 Regular Session

MEDICAL PSILOCYBIN ACT

SB 219, the Medical Psilocybin Act, allows regulated medical use of psilocybin (a compound found in certain mushrooms) to treat specific conditions including treatment-resistant depression, PTSD, substance use disorders, and end-of-life care. It removes psilocybin from New Mexico's controlled substances list for medical purposes, creating a program overseen by the Department of Health that requires clinicians and producers to obtain permits and follow safety protocols. The bill establishes an advisory board to help develop treatment guidelines and provides legal protections, exempting authorized use from criminal penalties while prohibiting use while driving under its influence. Qualified patients must be diagnosed with an approved condition by a licensed clinician within an approved setting, with the Department of Health required to implement the program by December 2027.

Issues: ✓ Healthcare

Bill status signed all 5 stages cleared

Introduction

Jan 2025

Committee Review

Mar 2025

Senate Passage

Mar 2025

House Passage

Mar 2025

Signed into Law

Apr 2025

Introduced Jan 30, 2025 Signed Apr 8, 2025

Maddy AI version diff · 2 comparisons

What changed between versions

JU substitute → Final Version · 5 edits

MODERATE

The bill was reformatted from a committee substitute version to a final legislative version, with substantive changes including the addition of a new Section 4 on federal FDA-approved product exemptions and the reorganization of penalty provisions into Sections 5 and 6. The core policy content regarding psilocybin use for medical conditions remains consistent between versions.

Scope change

The bill's scope was expanded to explicitly exempt federal FDA-approved psilocybin products from the new Medical Psilocybin Act, with specific exceptions for state research and patient-funded treatments.

EXEMPTIONS

Added Section 4 to exempt federal FDA-approved psilocybin products from the act, except for state research and patient-funded treatments.

ENFORCEMENT

Reorganized penalty provisions into two separate sections (5 and 6) to distinguish between criminal/civil exemptions and prohibitions with criminal penalties.

TECHNICAL

Changed document structure from committee substitute format to final legislative format with updated section numbering and removed bracketed markup.

DEFINITION

Added new definition for 'medical services' to include preparation, administration, and integration sessions.

Added new definition for 'secretary' to refer to the secretary of health.

Floor votes · Senate Mar 12, 2025 · House Mar 18, 2025

How they voted

32–4

Passed · 4 other

Total votes 40

Mar 12, 2025

D Democratic24

22 Yea 2

91% Yea

R Republican16

10 Yea 4 Nay 2

62% Yea

Vote distribution

All Yea All Nay Mixed No data

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Apr 8, 2025

Signed into law

Signed

executive

Mar 18, 2025

Lower · Passed

passed House

lower

Mar 17, 2025

Lower · Passed

DO PASS committee report adopted

lower

Mar 13, 2025

Introduced

Sent to House Health & Human Services Committee

lower

Mar 12, 2025

Upper · Passed

passed Senate

upper

Mar 12, 2025

Upper · Passed

floor substitute adopted (1 amendment)

upper

Mar 10, 2025

Upper · Passed

DO PASS committee report adopted

upper

Mar 6, 2025

Upper · Passed

DO NOT PASS, replaced with committee substitute

upper

Feb 12, 2025

Upper · Passed

DO PASS, as amended, committee report adopted

upper

Jan 30, 2025

Introduced

Sent to Senate Tax, Business and Transportation Committee & Senate Judiciary Committee & Senate Finance Committee

upper

5 primary · 0 co-sponsors